title: Effects of oxazepam and lorazepam on implicit and explicit memory: evidence for possible influences of time course.
abstract: The effects of oxazepam (30 mg), lorazepam (2 mg), and placebo on implicit and explicit memory were studied in two testing cycles, 100 and 170 min after drug administration. Thirty healthy volunteers were randomly assigned to one of three groups (placebo, oxazepam, or lorazepam) in a double-blind, independent groups design. Drug groups were equivalent prior to drug administration on a variety of cognitive measures. Following drug administration, both oxazepam and lorazepam equally impaired performance on a cued-recall explicit memory task relative to placebo, at both testing cycles. Relative to placebo, lorazepam markedly impaired priming on a word-stem completion implicit memory task, at both testing cycles. Consistent with previous work, oxazepam failed to produce impairments in priming on the word-stem completion task at 100 min post-drug administration. However, oxazepam was found significantly to impair priming on this latter task relative to placebo, at close to theoretical peak plasma concentration (i.e., 170 min post-drug administration). Explanations for the observed detrimental effect of oxazepam on implicit memory task performance are considered, including: possible time-dependent effects related to the relative rate of absorption of these two benzodiazepines (BZs); and potential contamination of the implicit memory task by explicit memory strategies during the second testing cycle.
authors.affiliation: Department of Psychology, Dalhousie University, Halifax, Nova Scotia, Canada.
authors.forename: S H
authors.initials: SH
authors.lastname: Stewart
authors.forename: G F
authors.initials: GF
authors.lastname: Rioux
authors.forename: J F
authors.initials: JF
authors.lastname: Connolly
authors.forename: S C
authors.initials: SC
authors.lastname: Dunphy
authors.forename: M D
authors.initials: MD
authors.lastname: Teehan
mesh_terms: D000293:Adolescent; D000328:Adult; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008140:Lorazepam / Q000494:pharmacology*; D008297:Male; D008568:Memory / Q000187:drug effects*; D010076:Oxazepam / Q000494:pharmacology*; D013997:Time Factors
chemical_list: D014151:Anti-Anxiety Agents; D010076:Oxazepam; D008140:Lorazepam